Mariner
INBX icon

Mariner’s Inhibrx INBX Stock Holding History

Mariner’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$433K Buy
+4,569
New +$458K ﹤0.01% 2555
2026
Q1 		– Sell
-12,746
Closed -$1.01M – 3689
2025
Q4 		$1.01M Sell
12,746
-4,596
-27% -$313K ﹤0.01% 1949
2025
Q3 		$584K Buy
17,342
+5,388
+45% +$133K ﹤0.01% 2308
2025
Q2 		$171K Sell
11,954
-6,713
-36% -$86.8K ﹤0.01% 3103
2025
Q1 		$261K Buy
+18,667
New +$253K ﹤0.01% 2762

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mariner's INBX Position: Q2 2026 in Review

Mariner opened a new position in Inhibrx (INBX) in Q2 2026: 4,569 shares worth $433K. The stake represents ﹤0.01% of the portfolio and ranks #2555 among its holdings. This is a return to the name: Mariner previously reported a position in INBX as recently as Q4 2025.

Mariner first reported a position in INBX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.01M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Mariner held 4,569 shares of Inhibrx worth $433K as of Q2 2026.
  • Inhibrx was a new Mariner position in Q2 2026.
  • Inhibrx made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2555 holding.
  • Mariner first reported a position in Inhibrx in Q1 2025 and has held it in 5 quarters since.
  • Mariner's Inhibrx position peaked at $1.01M in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.